Wednesday, November 08, 2017 10:15 PM ET
Insider Makes Significant Stock buy in Fortress Biotech (FBIO) Shares Breaks neutral Trend of Last 90 Days
There was noteworthy purchase activity in Fortress Biotech shares by an insider today, as disclosed in a form 4 document filed with the SEC. One insider — Dr Lindsay A Rosenwald, 10% Owner, Director and Officer — bought 40,000 shares in the company having a market value of approximately $1,000,000. This is the first insider buy/sell trade in the past 90 days.
Fortress Biotech buy-sell trading activity is close to the 42 member peer company average. The Biopharmaceuticals peer group saw 25 buy/sell trades during this period for an average of 0.6 transactions per company. However, trading at Fortress Biotech represents a lower number of shares per transaction. Within the peer group there were 2,350,858 shares purchased and 3,324,315 shares sold with company insiders disposing of 38,938 shares on average over this time period.
Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data obtained in creating and writing this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.